Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hoth Therapeutics, Inc. - Common Stock (NQ:HOTH)

0.9900 -0.0500 (-4.81%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 236,819
Open 1.020
Bid (Size) 1.000 (1,600)
Ask (Size) 1.020 (700)
Prev. Close 1.040
Today's Range 0.9900 - 1.034
52wk Range 0.6554 - 2.115
Shares Outstanding 23,873,626
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Hoth Therapeutics's GDNF Treatment Shows Superior Efficacy Over Wegovy, Ozempic In Preclinical Trial ↗
The company announced positive preclinical results from a study evaluating GDNF as a potential treatment for obesity and metabolic-associated steatotic liver disease. 
Via Stocktwits
BioMedNewsBreaks — Lantern Pharma Inc. (NASDAQ: LTRN) Advancing Drug Discovery with PredictBBB.ai(TM) Partnership
Via Investor Brand Network
Topics Artificial Intelligence

Performance

YTD
-7.5%
-7.5%
1 Month
+0.9%
+0.9%
3 Month
-5.7%
-5.7%
6 Month
-45.9%
-45.9%
1 Year
-15.4%
-15.4%

More News

Read More
Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-powered PredictBBB.ai Platform Helps Hoth Therapeutics Streamline Candidate Selection in Drug Development
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
3 Under-the-Radar Biotechs Under $5 That Could Soar 200% ↗
Via MarketBeat
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
Curious about the stocks that are showing activity after the closing bell on Tuesday? ↗
Via Chartmill
News headline image
Hoth Therapeutics, Inc. (NASDAQ: HOTH) Makes Headlines With Rapid Tumor Kill Data
Via News Direct
Hoth Therapeutics, Inc. (NASDAQ: HOTH) Makes Headlines With Rapid Tumor Kill Data
Via AB Newswire
News headline image
EXCLUSIVE: Hoth Therapeutics' Antisense Therapy Demonstrates Efficacy Against KIT-Driven Cancers ↗
Via Benzinga
News headline image
Top 5 Biotech Stocks With Strong Momentum ↗
Via Benzinga
News headline image
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
Via Get News
Topics Intellectual Property
News headline image
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
Via Press Release Distribution Service
Topics Intellectual Property
News headline image
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
The trading volume of these stocks is deviating from the norm in today's session. ↗
Via Chartmill
News headline image
What's going on in today's session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
Why Cal-Maine Foods Shares Are Trading Higher By 4%; Here Are 20 Stocks Moving Premarket ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Nasdaq Down 1.5%; RPM Posts Upbeat Results ↗
Via Benzinga
News headline image
Why Is Hoth Therapeutics Stock Flying Higher On Tuesday? ↗
Via Benzinga

Frequently Asked Questions

Is Hoth Therapeutics, Inc. - Common Stock publicly traded?
Yes, Hoth Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Hoth Therapeutics, Inc. - Common Stock trade on?
Hoth Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Hoth Therapeutics, Inc. - Common Stock?
The ticker symbol for Hoth Therapeutics, Inc. - Common Stock is HOTH on the Nasdaq Stock Market
What is the current price of Hoth Therapeutics, Inc. - Common Stock?
The current price of Hoth Therapeutics, Inc. - Common Stock is 0.9900
When was Hoth Therapeutics, Inc. - Common Stock last traded?
The last trade of Hoth Therapeutics, Inc. - Common Stock was at 03/18/26 04:00 PM ET
What is the market capitalization of Hoth Therapeutics, Inc. - Common Stock?
The market capitalization of Hoth Therapeutics, Inc. - Common Stock is 23.63M
How many shares of Hoth Therapeutics, Inc. - Common Stock are outstanding?
Hoth Therapeutics, Inc. - Common Stock has 24M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.